Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN

por Krege, John H, Rizzoli, Paul B, Liffick, Emily, Doty, Erin G, Dowsett, Sherie A, Wang, Jianing, Buchanan, Andrew S
Publicado 2019

Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls

por Pearlman, Eric M., Wilbraham, Darren, Dennehy, Ellen B., Berg, Paul H., Tsai, Max, Doty, Erin G., Kay, Gary G.
Publicado 2020

The Association Between the Occurrence of Common Treatment-Emergent Adverse Events and Efficacy Outcomes After Lasmiditan Treatment of a Single Migraine Attack: Secondary Analyses...

por Doty, Erin G., Hauck, Paula M., Krege, John H., Komori, Mika, Hake, Ann M., Dong, Yan, Lipton, Richard B.
Publicado 2022

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinica...

por Ashina, Messoud, Vasudeva, Raghavendra, Jin, Leah, Lombard, Louise, Gray, Elizabeth, Doty, Erin G., Yunes‐Medina, Laura, Kinchen, Kraig S., Tassorelli, Cristina
Publicado 2019

Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies

por Smith, Timothy, Krege, John H., Rathmann, Suchitrita S., Dowsett, Sherie A., Hake, Ann, Nery, Emel S. M., Matthews, Brandy R., Doty, Erin G.
Publicado 2020

Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study

por Ashina, Messoud, Reuter, Uwe, Smith, Timothy, Krikke-Workel, Judith, Klise, Suzanne R, Bragg, Sonja, Doty, Erin G, Dowsett, Sherie A, Lin, Qun, Krege, John H
Publicado 2021